Healthcare -
Biotechnology - NASDAQ - US
$ 1.565
7.19 %
$ 101 M
Market Cap
-1.01
P/E
INZY - CAPITAL EXPENDITURES
Capital Expenditures INZY - Inozyme Pharma, Inc.
-298 K
LAST VALUE
13.36%
2 YEAR CAGR
-2.85%
5 YEAR CAGR
0.00%
10 YEAR CAGR